Selling by month
Oct 2025 to Oct 2026. Each sale is counted once: under a disclosed plan, else to cover taxes, else no plan disclosed.
Disclosed planTo cover taxesOne dollar scale for every month; the tallest bar is labeled
Pattern
What the filings show, past 12 months. Nothing here rates or predicts.
- Sold in 2 of the 13 calendar months from Oct 2025 to Oct 2026: Dec 2025 and Mar 2026.
- Largest single sale: $505K (1,183 shares) of Madrigal Pharmaceuticals, Inc. on Mar 2, 2026. Filing
- Last sale before this period: Mar 10, 2025.
Roles from filings
Every company we track where this person has filed, newest filing first.
| Company | Title | First filing | Latest filing |
|---|---|---|---|
| Madrigal Pharmaceuticals, Inc. (MDGL) | EVP and CFO | Mar 21, 2024 | Mar 6, 2026 |
Recent filings
The last 4 days with transactions, newest first, one line per trade date. Each number links to an SEC filing.
- Mar 6, 2026, Madrigal Pharmaceuticals, Inc.: sold 1,982 shares for $854K, under a disclosed plan. 1 filing: 1
- Mar 4, 2026, Madrigal Pharmaceuticals, Inc.: 5,215 shares granted. 1 filing: 1
- Mar 2, 2026, Madrigal Pharmaceuticals, Inc.: sold 1,183 shares for $505K, to cover taxes. 1 filing: 1
- Dec 2, 2025, Madrigal Pharmaceuticals, Inc.: sold 4,173 shares for $2.4M, under a disclosed plan; 4,173 shares acquired by exercising options. 1 filing: 1
This page shows only what this person reported on SEC ownership filings. See the methodology. Spotted something wrong? Report an error.